Wang, Q., Guldner, I. H., Golomb, S. M., Sun, L., Harris, J. A., Lu, X., & Zhang, S. (2019). Single-cell profiling guided combinatorial immunotherapy for fast-evolving CDK4/6 inhibitor-resistant HER2-positive breast cancer. Nature Portfolio.
Cita Chicago Style (17a ed.)Wang, Qingfei, Ian H. Guldner, Samantha M. Golomb, Longhua Sun, Jack A. Harris, Xin Lu, y Siyuan Zhang. Single-cell Profiling Guided Combinatorial Immunotherapy for Fast-evolving CDK4/6 Inhibitor-resistant HER2-positive Breast Cancer. Nature Portfolio, 2019.
Cita MLA (8a ed.)Wang, Qingfei, et al. Single-cell Profiling Guided Combinatorial Immunotherapy for Fast-evolving CDK4/6 Inhibitor-resistant HER2-positive Breast Cancer. Nature Portfolio, 2019.
Precaución: Estas citas no son 100% exactas.